{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:40:12Z","timestamp":1790973612894,"version":"4.1.0"},"reference-count":19,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,7,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We examined whether monoclonal gammopathy of undetermined significance (MGUS) is increased in first-degree relatives of multiple myeloma (MM) or MGUS patients. Probands were recruited from a population-based prevalence study (MGUS) and the Mayo Clinic (MM). Serum samples were collected from first-degree relatives older than 40 years and subjected to electrophoresis and immunofixation. The prevalence of MGUS in relatives was compared with population-based rates. Nine-hundred eleven relatives of 232 MM and 97 MGUS probands were studied. By electrophoresis, MGUS was detected in 55 (6%) relatives, and immunofixation identified 28 additional relatives for an age- and sex-adjusted prevalence of 8.1% (95% CI, 6.3 to 9.8). The prevalence of MGUS in relatives increased with age (1.9%, 6.9%, 11.6%, 14.6%, 21.0% for ages 40-49, 50-59, 60-69, 70-79, \u2265 80 years, respectively; P &lt; .001). Using similar MGUS detection methods, there was a higher risk of MGUS in relatives (age-adjusted risk ratio [RR], 2.6; 95% CI, 1.9 to 3.4) compared with the reference population. The increased risk was seen among relatives of MM (RR, 2.0; 95% CI, 1.4 to 2.8) and MGUS probands (RR, 3.3; 95% CI, 2.1 to 4.8). The increased risk of MGUS in first-degree relatives of MGUS or MM patients implies shared environment and\/or genetics.<\/jats:p>","DOI":"10.1182\/blood-2008-12-192575","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T21:58:20Z","timestamp":1233266300000},"page":"785-790","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":133,"title":["Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance"],"prefix":"10.1182","volume":"114","author":[{"given":"Celine M.","family":"Vachon","sequence":"first","affiliation":[{"name":"Division of Epidemiology, Department of Health Sciences Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry M.","family":"Therneau","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Health Science Research, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Foreman","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Health Sciences Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk R.","family":"Larson","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Health Science Research, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Colby","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Health Science Research, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara K.","family":"Phelps","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji K.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry A.","family":"Katzmann","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, College of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111723195589100_B1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis of monoclonal gammopathy of undetermined significance.","volume":"346","author":"Kyle","year":"2002","journal-title":"New Engl J Med"},{"key":"2019111723195589100_B2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"New Engl J Med"},{"key":"2019111723195589100_B3","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0025-6196(11)61089-6","article-title":"Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.","volume":"82","author":"Landgren","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"2019111723195589100_B4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"key":"2019111723195589100_B5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9343(98)00080-1","article-title":"Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly.","volume":"104","author":"Cohen","year":"1998","journal-title":"Am J Med"},{"key":"2019111723195589100_B6","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0025-6196(11)61090-2","article-title":"Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan.","volume":"82","author":"Iwanaga","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"2019111723195589100_B7","first-page":"66","article-title":"Familiality of benign and malignant paraproteinemias: a population-based cancer-registry study of multiple myeloma families.","volume":"90","author":"Ogmundsd\u00f3ttir","year":"2005","journal-title":"Haematologica"},{"key":"2019111723195589100_B8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00051914","article-title":"Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study.","volume":"3","author":"Eriksson","year":"1992","journal-title":"Cancer Causes Control"},{"key":"2019111723195589100_B9","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2385::AID-CNCR13>3.0.CO;2-A","article-title":"Multiple myeloma and family history of cancer among blacks and whites in the U.S.","volume":"85","author":"Brown","year":"1999","journal-title":"Cancer"},{"key":"2019111723195589100_B10","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/1097-0142(19851015)56:8<2133::AID-CNCR2820560842>3.0.CO;2-F","article-title":"Multiple myeloma and family history of cancer: a case-control study.","volume":"56","author":"Bourguet","year":"1985","journal-title":"Cancer"},{"key":"2019111723195589100_B11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4065\/71.3.266","article-title":"History of the Rochester Epidemiology Project.","volume":"71","author":"Melton","year":"1996","journal-title":"Mayo Clinic Proc"},{"key":"2019111723195589100_B12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s001980050050","article-title":"Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival.","volume":"8","author":"Melton","year":"1998","journal-title":"Osteoporos Int"},{"key":"2019111723195589100_B13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0025-6196(11)60739-8","article-title":"Genetic predisposition for monoclonal gammopathy of undetermined significance.","volume":"83","author":"Ruiz-Delgado","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"2019111723195589100_B14","first-page":"471","article-title":"Familial multiple myeloma.","volume":"57","author":"Alexander","year":"1965","journal-title":"J Natl Med Assoc"},{"key":"2019111723195589100_B15","first-page":"278","article-title":"Familial multiple myeloma: II, Final pathological findings in two brothers and a sister.","volume":"59","author":"Alexander","year":"1967","journal-title":"J Natl Med Assoc"},{"key":"2019111723195589100_B16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJMoa0708704","article-title":"Familial myeloma.","volume":"359","author":"Lynch","year":"2008","journal-title":"New Engl J Med"},{"key":"2019111723195589100_B17","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.1999.01415.x","article-title":"Familial multiple myeloma: report of fifteen families.","volume":"105","author":"Grosbois","year":"1999","journal-title":"Br J Haematol"},{"key":"2019111723195589100_B18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.22718","article-title":"Multiple myeloma: a review of the epidemiologic literature.","volume":"120","author":"Alexander","year":"2007","journal-title":"Int J Cancer"},{"key":"2019111723195589100_B19","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/114\/4\/785\/1321630\/zh803009000785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/114\/4\/785\/1321630\/zh803009000785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T23:20:07Z","timestamp":1574032807000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/114\/4\/785\/26115\/Increased-risk-of-monoclonal-gammopathy-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,23]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-12-192575","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1160428.620786","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,23]]}}}